Oral administration of bromelain and acetylcysteine in pseudomyxoma peritonei (PMP) caused by low-grade appendiceal mucinous neoplasm (LAMN): a case report.

Dominik Geisel, Ute Langen, Thomas Rüdiger

Journal: Journal of medical case reports 2023;17(1):297

PMID: 37381056

Abstract

BACKGROUND

Pseudomyxoma Peritonei (PMP) is a severe neoplastic clinical syndrome characterised by secretion of mucin from tumors often originating in the appendix. The standard treatment includes cytoreductive surgery (CRS) combined with heated intraperitoneal chemotherapy (HIPEC). A new perspective in PMP treatment aims at the mucins themselves as a therapeutic target.

CASE PRESENTATION

Here we report the first case of PMP with peritoneal dissemination of mucinous implants caused by low-grade appendiceal mucinous neoplasm (LAMN) in a 58-year-old white male exclusively treated by appendectomy and oral administration of bromelain and acetylcysteine in the context of a medical self-experimentation (by co-author T.R.). Observation so far covers a period of 48 months including regular magnetic resonance imaging (MRI) with stable findings.

CONCLUSIONS

Oral administration of bromelain and acetylcysteine can be used in the treatment of PMP caused by LAMN without relevant clinical side effects.

© 2023. The Author(s).

Address: Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik Für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany. [email protected].; Department of Radiology, Charité, Universitätsmedizin Berlin, Campus Virchow-Klinikum, Klinik Für Radiologie, Augustenburger Platz 1, 13353, Berlin, Germany.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.